Social Media Strategies for Drug & Device Companies Practical Tips and Tools to Use in the Absence of FDA Guidance
Product Details
Facebook and Twitter. They ought to represent the marketing breakthrough of the new century. But so far, they’re techniques that could cause you trouble.
While there has been lots of talk, the FDA has failed to issue guidance, leaving drug- and devicemakers in the dark — and vulnerable to sanctions.
With surveys showing 60% of Americans turn first to the Internet when seeking health information, is there a safe way to get your message out via social media?
The answer is yes — when you know what you’re doing.
Clear your calendar for Thursday, Sept. 29 and plan to spend the day near a computer screen. It’s the marketing event of the year, a Virtual Social Media Conference sponsored by FDAnews featuring top experts in marketing, advertising, technology, regulation and law.
Washington comes to YOU
You’ll discover the DDMAC’s latest thinking on issuance of that long-awaited social media guidance — the issues, the hang-ups, the politics and, most important, the likely timeline.
You’ll pick up pointers on selling social media to your bosses — arguments that convince decisionmakers on the potential rewards of these new advertising and marketing channels.
Small and mid-sized drug and device companies will gain from successes of the big boys, with case studies of AstraZeneca’s tweet chats and Eli Lilly’s “Lillypad” blog.
Lack a clue on how to measure the impact of social media campaigns? Learn how to identify definable points for scoring the victories and the flops, and put numbers to intangibles such as user comments.
What about that hack of Pfizer’s Facebook page? Could it happen to you? We’ve scheduled an entire panel on moderating Facebook pages for adverse events and maintaining page security. In it, you’ll discover how to keep Facebook discussions rolling while complying with AER requirements ... distinguish between mere dissatisfaction and actual adverse events ... and much more.
No Planes, No Trains, No Automobiles
Why board a Washington-bound plane, check into an unfamiliar hotel and spend two or three days away from your desk to attend a conference?
With an FDAnews Virtual Conference, you don’t need to.
-
Stress-free — No airport security hassles or waking at 4 a.m. to catch an early flight. You never even leave your building — not even your own desk.
-
Interactive — Constant opportunities to ask questions and get involved. Send in queries via e-mail ... you’ll have answers before you log off.
-
Up-to-the-minute — Every speaker operates in the real world, in real time. If something important happens on Virtual Conference morning, you’ll hear about it before the sessions end.
-
Great value — Spread the word! There’s no limit on number of attendees per site. One low registration fee covers them all. Or register three or more locations for deeper discounts still. Get details here.
Here’s How It Works
Twenty-four hours prior to Virtual Conference Thursday, attendees will receive all presentations.
Then just log on to the Virtual Conference website and dial a toll-free number, both provided in your registration confirmation. And relax. That’s all there is to it.
Who Will Benefit
Every marketing, advertising and communications specialist in your organization is a candidate to participate in this Virtual Conference. So are general and outside counsel, regulatory and compliance staff, and top management, too. You’ll even want to notify the folks you work with at ad, marketing and tech/IT consulting firms. Spread the word!